Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
93
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Microwave Ablation of Small Hepatic Metastases Using MR Guidance and Monitoring: Clinical Safety and Efficacy

Zhaonan Li1 Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-3055-8817
ORCID Icon,
Dechao Jiao1 Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, People’s Republic of China
,
Chaoyan Wang1 Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, People’s Republic of China
,
Jing Li1 Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, People’s Republic of China
,
Zaoqu Liu1 Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, People’s Republic of China
,
Wenguang Zhang1 Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, People’s Republic of China
&
Xinwei Han1 Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4460-8619
ORCID Icon show all
Pages 3357-3366 | Published online: 16 Apr 2021

References

  • Gordic S, Corcuera-Solano I, Stueck A, et al. Evaluation of HCC response to locoregional therapy: validation of MRI-based response criteria versus explant pathology. J Hepatol. 2017;67(6):1213–1221. doi:10.1016/j.jhep.2017.07.03028823713
  • O’Leary C, Mahler M, Soulen MC. Curative-intent therapies in localized hepatocellular carcinoma. Curr Treat Options Oncol. 2020;21(4):31. doi:10.1007/s11864-020-0725-332193784
  • Zhou J, Sun HC, Wang Z, et al. Guidelines for diagnosis and treatment of primary liver cancer in China (2017 Edition). Liver Cancer. 2018;7(3):235–260. doi:10.1159/00048803530319983
  • Xu Z, Xie H, Zhou L, et al. The combination strategy of transarterial chemoembolization and radiofrequency ablation or microwave ablation against hepatocellular carcinoma. Anal Cell Pathol (Amst). 2019;2019:8619096. doi:10.1155/2019/861909631534899
  • Park MH, Rhim H, Kim YS, et al. Spectrum of CT findings after radiofrequency ablation of hepatic tumors. Radiographics. 2008;28(2):379–90, 390–2. doi:10.1148/rg.282075038
  • Hoffmann R, Rempp H, Kessler DE, et al. MR-guided microwave ablation in hepatic tumours: initial results in clinical routine. Eur Radiol. 2017;27(4):1467–1476. doi:10.1007/s00330-016-4517-x27553935
  • Dong J, Geng X, Yang Y, et al. Dynamic imaging and pathological changes in pig liver after MR-guided microwave ablation. BMC Cancer. 2018;18(1):397. doi:10.1186/s12885-018-4157-429625559
  • Weiss J, Winkelmann MT, Gohla G, et al. MR-guided microwave ablation in hepatic malignancies: clinical experiences from 50 procedures. Int J Hyperthermia. 2020;37(1):349–355. doi:10.1080/02656736.2020.175071332286087
  • Yu NC, Chaudhari V, Raman SS, et al. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9(2):161–167. doi:10.1016/j.cgh.2010.09.01720920597
  • Clasen S, Rempp H, Hoffmann R, et al. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance? Eur J Radiol. 2014;83(1):111–116. doi:10.1016/j.ejrad.2013.09.01824161781
  • Rempp H, Waibel L, Hoffmann R, et al. MR-guided radiofrequency ablation using a wide-bore 1.5-T MR system: clinical results of 213 treated liver lesions. Eur Radiol. 2012;22(9):1972–1982. doi:10.1007/s00330-012-2438-x22527377
  • Kudo M. Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology. 2010;78(Suppl 1):113–124. doi:10.1159/00031523920616593
  • Ng KK, Poon RT, Lo CM, et al. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg. 2008;12(1):183–191. doi:10.1007/s11605-007-0276-y17874276
  • Facciorusso A, Del PV, Antonino M, et al. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation. Dig Liver Dis. 2014;46(11):1014–1019. doi:10.1016/j.dld.2014.07.01225085684
  • Morikawa S, Inubushi T, Kurumi Y, et al. MR-guided microwave thermocoagulation therapy of liver tumors: initial clinical experiences using a 0.5 T open MR system. J Magn Reson Imaging. 2002;16(5):576–583. doi:10.1002/jmri.1019812412035
  • Clasen S, Pereira PL. Magnetic resonance guidance for radiofrequency ablation of liver tumors. J Magn Reson Imaging. 2008;27(2):421–433. doi:10.1002/jmri.2126418219677
  • Jia ZY, Chen QF, Yang ZQ, et al. Early assessment of coagulation necrosis after hepatic microwave ablation: a comparison of non-enhanced and enhanced T1-weighted images. Abdom Radiol (NY). 2017;42(6):1781–1787. doi:10.1007/s00261-017-1064-028180923
  • Chen J, Lin Z, Lin Q, et al. Percutaneous radiofrequency ablation for small hepatocellular carcinoma in hepatic dome under MR-guidance: clinical safety and efficacy. Int J Hyperthermia. 2020;37(1):192–201. doi:10.1080/02656736.2020.172839732066293
  • Weiss J, Hoffmann R, Rempp H, et al. Feasibility, efficacy, and safety of percutaneous MR-guided ablation of small (</=12 mm) hepatic malignancies. J Magn Reson Imaging. 2019;49(2):374–381. doi:10.1002/jmri.2625230221797

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.